|
Real-time Estimate
Cboe BZX
15:18:47 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.615 USD | -0.98% |
|
+2.12% | -8.38% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 06-01 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
IMTX 9.615 $
-0.98%
247K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| IMTX | 9.615USD | -0.98% | 247K $ | |
Deutsche Boerse AG
| 4A3 | 8.300EUR | -2.92% | 12.04K € | |
|
Börse Stuttgart
| 4A3 | 8.325EUR | -0.36% | 10.56K € | |
|
CBOE
| IMTX | 9.610USD | -1.03% | 6.89K $ | |
|
Tradegate
| 4A3 | 8.535EUR | +1.25% | 42.68 € | |
|
Boerse Muenchen
| 4A3 | 8.450EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bullish |
| Resistance | 10.26 | 10.26 | 11.62 |
| Spread/Res. | -6.24% | -6.24% | -17.21% |
| Spread/Supp. | +11.47% | +11.47% | +15.63% |
| Support | 8.63 | 8.63 | 8.32 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
